EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Polygenic score integrating neurodegenerative and vascular risk informs dementia risk stratification

Tim D'Aoust iD, Santiago Clocchiatti-Tuozzo, Cyprien A Rivier, Aniket Mishra, Tsuyoshi Hachiya, Benjamin Grenier-Boley, Aïcha Soumaré, Marie-Gabrielle Duperron, Quentin Le Grand, Vincent Bouteloup, Cécile Proust-Lima, Cécilia Samieri und 14 weitere

Alzheimer's & Dementia · 2025-03 · 21 (3)

DOI: 10.1002/alz.70014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 05.03.2025. Verfasst von Tim D'Aoust und 25 weiteren Autor:innen. Beteiligte Einrichtung: Bordeaux Population Health Center, INSERM, UMR U1219, University of Bordeaux, Bordeaux, France. Hauptthemen laut MEDLINE: Multifactorial Inheritance, Dementia, Genetic Predisposition to Disease, Neurodegenerative Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fondation Plan Alzheimer, NIH HHS, Conseils Régionaux of Aquitaine and Bourgogne.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION An integrative polygenic risk score (iPRS) capturing the neurodegenerative and vascular contribution to dementia could identify high‐risk individuals and improve risk prediction. METHODS We developed an iPRS for dementia (iPRS‐DEM) in Europeans (aged 65+), comprising genetic risk for Alzheimer's disease (AD) and 23 vascular or neurodegenerative traits (excluding apolipoprotein E [ APOE ]). iPRS‐DEM was evaluated across cohorts comprising older community‐dwelling people ( N = 3702), a multi‐ancestry biobank ( N = 130,797 Europeans; 105,404 non‐Europeans), and dementia‐free memory clinic participants ( N = 2032). RESULTS iPRS‐DEM was associated with dementia risk independently of APOE in the elderly (subdistribution hazard ratio [sHR] per1SD = 1.15, 95% confidence interval [CI]: 1.03 to 1.28), which generalized to Europeans (EUR‐sHR per1SD = 1.28, 95% CI: 1.09 to 1.51]), East‐Asians (EAS‐sHR per1SD = 5.29, 95% CI: 1.43 to 34.36), and memory‐clinic participants (sHR per1SD = 1.25, 95% CI: 1.11 to 1.42). Prediction was comparable to clinical risk factors in older community‐dwelling people, with improved performance among memory‐clinic patients. Risk stratification was enhanced by defining four genetic risk groups with iPRS‐DEM and APOE ε4, reaching five‐fold increased risk in APOE ε4+/iPRS‐DEM+ memory‐clinic participants. DISCUSSION Alongside APOE ε4, iPRS‐DEM may refine risk stratification for the enrichment of dementia clinical trials and prevention programs. Highlights iPRS‐DEM reflects neurodegenerative and vascular contribution to dementia. We show iPRS‐DEM captures additional dementia genetic risk beyond APOE and AD‐PRS. iPRS‐DEM, in combination with APOE ε4, shows promise for dementia risk stratification. Our results generalize across both population‐based and memory‐clinic settings. We show transportability of iPRS‐DEM to East Asian ancestry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multifactorial InheritanceDementiaGenetic Predisposition to DiseaseNeurodegenerative DiseasesHumansFemaleMaleAgedRisk AssessmentRisk FactorsApolipoproteins EAged, 80 and overWhite PeopleAlzheimer DiseaseCohort Studies

Stichwörter der Autor:innen

apolipoprotein E genotypecommunity‐dwelling elderlycompeting risk analysisdementia preventionincident dementialongitudinal studymemory clinicmulti‐ancestry biobankpolygenic risk scoretransportability of PRSvascular cognitive impairment

Substanzen

Apolipoproteins E

Autor:innen und Institutionen

  • Bordeaux Population Health Center, INSERM, UMR U1219, University of Bordeaux, Bordeaux, France.
  • Department of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.
  • Center for Brain and Mind Health, Yale School of Medicine, New Haven, Connecticut, USA.
  • Iwate Tohoku Medical Megabank Organization, Iwate Medical University, Yahaba, Iwate, Japan.
  • U1167-RID-AGE facteurs de risque et déterminants moléculaires des maladies liées au vieillissement, INSERM, Institut Pasteur de Lille, CHU Lille, University of Lille, Lille, France.
  • Department of Neurology, Institute for Neurodegenerative Diseases, CHU de Bordeaux, Bordeaux, France.

ORCID-Profile: Tim D'Aoust

Förderung

  • Fondation Plan Alzheimer
  • NIH HHS
  • Conseils Régionaux of Aquitaine and Bourgogne
  • Prix Fondation Claude Pompidou
  • Prix NRJ-neurosciences Académie des Sciences
  • Mutuelle Générale de l'Education Nationale (MGEN)
  • Prix Burrus, Fondation pour la Recherche Médicale
  • French Ministry of Research

Zitieren

APA

D'Aoust, T., Clocchiatti-Tuozzo, S., Rivier, C. A., Mishra, A., Hachiya, T., Grenier-Boley, B., Soumaré, A., Duperron, M. G., Le Grand, Q., Bouteloup, V., Proust-Lima, C., Samieri, C., Neuffer, J., Sargurupremraj, M., Chêne, G., Helmer, C., Thibault, M., Amouyel, P., Lambert, J. C., …, & Debette, S. (2025). Polygenic score integrating neurodegenerative and vascular risk informs dementia risk stratification. Alzheimer's & Dementia, 21(3). https://doi.org/10.1002/alz.70014

Vancouver

D'Aoust T, Clocchiatti-Tuozzo S, Rivier CA, Mishra A, Hachiya T, Grenier-Boley B, et al. Polygenic score integrating neurodegenerative and vascular risk informs dementia risk stratification. Alzheimer's & Dementia. 2025;21(3). doi:10.1002/alz.70014

BibTeX
@article{DAoust2025,
  author = {D'Aoust, Tim and Clocchiatti-Tuozzo, Santiago and Rivier, Cyprien A and Mishra, Aniket and Hachiya, Tsuyoshi and Grenier-Boley, Benjamin and Soumaré, Aïcha and Duperron, Marie-Gabrielle and Le Grand, Quentin and Bouteloup, Vincent and Proust-Lima, Cécile and Samieri, Cécilia and Neuffer, Jeanne and Sargurupremraj, Muralidharan and Chêne, Geneviève and Helmer, Catherine and Thibault, Mura and Amouyel, Philippe and Lambert, Jean-Charles and Kamatani, Yoichiro and Jacqmin-Gadda, Hélène and Tregouët, David-Alexandre and Inouye, Michael and Dufouil, Carole and Falcone, Guido J and Debette, Stéphanie},
  title = {Polygenic score integrating neurodegenerative and vascular risk informs dementia risk stratification},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {3},
  doi = {10.1002/alz.70014}
}
Kostenlos starten →